Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive ...
The US FDA recently approved ceftaroline fosamil (ceftaroline) for the treatment of acute bacterial skin and soft structure infections (ABSSSIs) and community-acquired pneumonia. In 2010 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback